Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor

Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and l...

Full description

Saved in:

Bibliographic Details
Main Author:	Ng,, Woei Kean
Format:	Thesis
Language:	English
Published:	2017
Subjects:	R735-854 Medical education Medical schools Research
Online Access:	http://eprints.usm.my/45441/1/NG%20WOEI%20KEAN.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.45441
record_format	uketd_dc
spelling	my-usm-ep.454412019-09-17T06:44:13Z Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor 2017-08 Ng,, Woei Kean R735-854 Medical education. Medical schools. Research Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and ligands are therefore needed to guarantee highest reproducibility and sensitivity possible. The complexity of pinning antibodies forms the key factor in interfering the outcome of an assay as the recognition molecule, i.e. the antibody itself, may have undergone structural changes and distortion when it is attached to the solid phase. 2017-08 Thesis http://eprints.usm.my/45441/ http://eprints.usm.my/45441/1/NG%20WOEI%20KEAN.pdf application/pdf en public phd doctoral Universiti Sains Malaysia Institut Penyelidikan Perubatan Molekul
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	R735-854 Medical education Medical schools Research
spellingShingle	R735-854 Medical education Medical schools Research Ng,, Woei Kean Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
description	Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and ligands are therefore needed to guarantee highest reproducibility and sensitivity possible. The complexity of pinning antibodies forms the key factor in interfering the outcome of an assay as the recognition molecule, i.e. the antibody itself, may have undergone structural changes and distortion when it is attached to the solid phase.
format	Thesis
qualification_name	Doctor of Philosophy (PhD.)
qualification_level	Doctorate
author	Ng,, Woei Kean
author_facet	Ng,, Woei Kean
author_sort	Ng,, Woei Kean
title	Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_short	Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_full	Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_fullStr	Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_full_unstemmed	Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_sort	development of antibody immobilisation strategy using recombinant human neonatal fc receptor
granting_institution	Universiti Sains Malaysia
granting_department	Institut Penyelidikan Perubatan Molekul
publishDate	2017
url	http://eprints.usm.my/45441/1/NG%20WOEI%20KEAN.pdf
_version_	1747821511089061888

Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor

Similar Items